TRENDING KEYWORDS
SmileDirectClub (SDC, $5.12) misses Q2 expectations
Shares of SmileDirectClub dropped on Tuesday, followed by second quarter results that came in lower than expected by analysts.
The teledentistry company’s second-quarter net loss of -14 cents a share was wider than the -12 cents a share anticipated by analysts surveyed by FactSet. Revenue came in at $174.2 million, compared to $198.5 million expected by analysts polled by FactSet.
For the year, the company projects a revenue range of $750 million to $800 million. FactSet's poll reveals analysts’ expectation of $783.4 million.
SDC in downward trend: 10-day moving average crossed below 50-day moving average on April 18, 2022
The 10-day Moving Average for SDC crossed bearishly below the 50-day moving average on April 18, 2022. This indicates that the trend has shifted lower and could be considered a sell signal. In 7 of 8 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 88%.
Current price $1.35 is below $1.82 the lowest resistance line found by A.I. Throughout the month of 04/13/22 - 05/16/22, the price experienced a -43% Downtrend. During the week of 05/09/22 - 05/16/22, the stock fell -11%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SDC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.
The Aroon Indicator for SDC entered a downward trend on May 16, 2022. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where SDC's RSI Oscillator exited the oversold zone, 12 of 15 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 80%.
The Stochastic Indicator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
SDC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Tickeron has a negative outlook on this ticker and predicts a further decline by more than 4.00% within the next month with a likelihood of 79%. During the last month, the daily ratio of advancing to declining volumes was 1 to 2.92.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SDC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
The Tickeron Price Growth Rating for this company is 95 (best 1 - 100 worst), indicating slightly worse than average price growth. SDC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 32 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.141) is normal, around the industry mean (7.459). P/E Ratio (0.000) is within average values for comparable stocks, (92.284). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.305). Dividend Yield (0.000) settles around the average of (0.019) among similar stocks. P/S Ratio (0.948) is also within normal values, averaging (95.433).
The Tickeron SMR rating for this company is 7 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
The average market capitalization across the Medical Specialties Industry is 5.8B. The market cap for tickers in the group ranges from 775 to 3.9T. MKYSF holds the highest valuation in this group at 3.9T. The lowest valued company is BIIO at 775.
The average weekly price growth across all stocks in the Medical Specialties Industry was 0.4%. For the same Industry, the average monthly price growth was -14.3%, and the average quarterly price growth was -31.79%. PMSNF experienced the highest price growth at 53%, while TNON experienced the biggest fall at -83.59%.
- 4/27/22 5:34 AM: SmileDirectClub (SDC, $1.97) is a top weekly loser for penny stocks, falling -15.81%
- 4/6/22 8:51 AM: SmileDirectClub (SDC, $2.49) is a top weekly loser for penny stocks, falling -15.02%
- 3/19/22 4:49 AM: SmileDirectClub (SDC, $2.84) is a top weekly gainer for penny stocks, rising +37.86%
The average weekly volume growth across all stocks in the Medical Specialties Industry was -13.53%. For the same stocks of the Industry, the average monthly volume growth was -19.1% and the average quarterly volume growth was -10.39%
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Stocks in the group have a Negative Outlook today, backed by the Aroon Indicator. Tickeron has a negative outlook on this group and predicts a further decline by more than 4.00% within the next month with a likelihood of 35%. During the last month, the daily ratio of advancing to declining volumes was 1 to 1.43.
50 stocks in the group of tickers exhibit a similar negative trend based on the Declines indicator with an average likelihood of 80%.
The most notable companies in this group are DaVita (NYSE:DVA), Guardant Health (NASDAQ:GH), SmileDirectClub (NASDAQ:SDC).
The average market capitalization across the group is 1.4B. The market cap for tickers in the group ranges from 0 to 17.1B. FMS holds the highest valuation in this group at 17.1B. The lowest valued company is BMCS at 0.
The average weekly price growth across all stocks in the group was 0.82%. For the same group, the average monthly price growth was -15.43%, and the average quarterly price growth was -32.05%. PNTG experienced the highest price growth at 36.8%, while KONEF experienced the biggest fall at -38.4%.
- 5/14/22 4:23 AM: agilon health (AGL, $19.17) was a top weekly gainer, with a +8.49% jump
- 5/14/22 4:23 AM: Cano Health (CANO, $5.15) was a top weekly gainer, with a +7.07% jump
- 5/14/22 4:23 AM: 1Life Healthcare (ONEM, $8.37) was a top weekly gainer, with a +7.72% jump
The average weekly volume growth across all stocks in the group was 26.35%. For the same stocks of the group, the average monthly volume growth was -17.79% and the average quarterly volume growth was 30.24%
- 5/11/22 7:40 AM: The volume for Tivity Health stock increased for four consecutive days, resulting in a record-breaking daily growth of 68% of the 65-Day Volume Moving Average
- 5/11/22 7:39 AM: The volume for Guardant Health stock increased for one day, resulting in a record-breaking daily growth of 255% of the 65-Day Volume Moving Average
- 5/7/22 5:22 AM: The volume for Global Cord Blood stock increased for one day, resulting in a record-breaking daily growth of 248% of the 65-Day Volume Moving Average
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Latest blogs by Sarah Patel
Top Blogs
